Skip to main navigation Skip to search Skip to main content

CTU: FORAGER-1: A Phase 1, Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Locally Advanced or Metastatic Solid Tumors Including Urothelial Cancer with FGFR3 Alterations

  • Zhang, Alison (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Quinlan, Gabriel (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)
  • Garcia, Michelle (Clinical Trial Unit Staff)
  • Armstrong, Emilia (Clinical Trial Unit Staff)
  • Lawrie, Angus (Clinical Trial Unit Staff)
  • Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleLOXO-FG3-22001
AcronymFORAGER-1
StatusActive
Effective start/end date12/11/251/02/27